# Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

> **NCT00002521** · PHASE2 · COMPLETED · sponsor: **Temple University**

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** syngeneic bone marrow transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002521
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-02
- **Primary completion:** 2000-02
- **Final completion:** 2000-02
- **Target enrollment:** — (—)
- **Last updated:** 2010-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002521, "Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00002521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*